glp-1 drugs metformin Emerging research suggests that medications like Ozempic and Wegovy might be beneficial for people with MS. Researchers are exploring how maintaining a healthy weight impacts MS symptoms and how like Battle of the diabetes drugs:

Source: Segal SHAPE, Segals data warehouse, 2018 to 2022 Even though many plans currently do not cover weight-loss medications, these plans are still seeing the effect that the GLP-1 medication class is having on their diabetic plan spend

Braca, S

46 Liraglutide is not currently subsidised by the PBS and therefore incurs additional out-of-pocket expenses for patients but is not limited by PBS restrictions on combination prescribing

63 Given known disparities in hypertension prevalence, control rates, and treatment response across racial groups, 64 further research is needed to assess whether GLP-1 RAs provide comparable benefits across diverse populations

It has been shown that the administration of the GLP-1 receptor agonist exendin-4 results in the expansion of pancreatic duct glands in rats, and acceleration of the formation of dysplastic lesions and chronic pancreatitis in the KrasG12D mouse model [63]